Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NOVN

Novan (NOVN) Stock Price, News & Analysis

Novan logo

About Novan Stock (NASDAQ:NOVN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
7.19 million shs
Average Volume
602,421 shs
Market Capitalization
$2.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NOVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter.

NOVN Stock News Headlines

Novartis AG
Novartis AG Registered Shares
Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
Novartis AG Registered Shares NOVN
Novan reaches deals to sell assets in bankruptcy case
Firm Retention Summary: Novan
See More Headlines

NOVN Stock Analysis - Frequently Asked Questions

Novan, Inc. (NASDAQ:NOVN) issued its earnings results on Monday, May, 15th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.22. The firm earned $3.17 million during the quarter, compared to analysts' expectations of $6.19 million. Novan had a negative trailing twelve-month return on equity of 700.28% and a negative net margin of 128.61%.
Read the conference call transcript
.

Novan (NOVN) raised $46 million in an initial public offering (IPO) on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novan investors own include Meta Platforms (META), Bionano Genomics (BNGO), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), NIO (NIO), Tesla (TSLA) and Zomedica (ZOM).

Company Calendar

Last Earnings
5/15/2023
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NOVN
Employees
90
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.31 million
Net Margins
-128.61%
Pretax Margin
-128.39%

Debt

Sales & Book Value

Annual Sales
$24.71 million
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
N/A

Miscellaneous

Free Float
27,651,000
Market Cap
$2.64 million
Optionable
Not Optionable
Beta
-0.06

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:NOVN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners